|Day Low/High||251.52 / 254.01|
|52 Wk Low/High||124.54 / 247.44|
Robots can't catch Covid-19, or anything else. While the rest of us stay home, they can keep factory output going with a minimum of human intervention.
Market leadership may be lacking on Thursday despite rising trading volumes, plus an update on Apple, Microsoft, Mastercard, Amazon and Gilead.
Look for weaknesses in companies like these that can provide solutions to today's pressing issues.
The stock of the medical device maker has been stagnant for months and its charts have yet to prove themselves.
If there was not a sizable addressable market for Beyond Meat, the competition would not be building as quickly as it is.
Top picks in the fast-growing medical products market.
And as the semiconductor sector continues to shine, Brooks Automation is a name to keep in mind.
To effectively generate profits, a trader must pick several companies in a sector and short the whole bunch.
Upgrades Dova Pharmaceuticals upgraded to Outperform from In-line at Evercore ISI Meridian Bancorp upgraded to Overweight from Neutral at Piper Jaffray; price target raised to $20 Landstar System upgraded to Mkt Perform from Underperform at Raymo...
Netflix led the charge in FANG names. And why MRCY is now a hot stock in the defense sector.
What we have seen of late from a number of chip producers really might be interpreted as pre-recessionary.
If you currently hold Stryker shares, consider selling and swapping into much better values.
It becomes difficult for me to tell you where to run in these markets...
Here are some options strategies for this FANG name into tomorrow's report.
The crash of oil will only accelerate the move.
KLA-Tencor, Microsoft and Intel all report earnings after the close Thursday.
Sectors are saying different things about rates, but new Fed chief Jerome Powell could provide clarity at his first press conference on Wednesday.
You might actually be grateful that stocks took one on the jaw on Monday.
The forces that artificially impacted the marketplace return to normal; so will the marketplace itself.
Demand for artificial joints is growing, and Zimmer Biomet is a good way to play the demographic trend.
It's a wonder to me how split this market really is.
We know that we are in the era when index managers are ascendant.
There are nearly too many surging sectors to count.
A one-day pullback wouldn't turn me into a bear.
Investors shouldn't be buying certain healthcare stocks based on Donald Trump's nomination of Tom Price as HHS chief, says Jim Cramer.